Skip to main content

Voyager Therapeutics, Inc.

VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001640266

No open-market purchases or sales by Voyager Therapeutics, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $122.7M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Voyager Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
128
+2 vs. Q2 2024
Shares held
35.1M
+2.32M (+7.1%) vs. Q2 2024
Total value
$205.9M
−$53.7M (−20.7%) vs. Q2 2024
New holders
20
38 more added
Sold out
18
36 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VYGR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 128 institutions
Q1 2021: 101 institutionsQ2 2021: 78 institutionsQ3 2021: 69 institutionsQ4 2021: 59 institutionsQ1 2022: 70 institutionsQ2 2022: 78 institutionsQ3 2022: 69 institutionsQ4 2022: 70 institutionsQ1 2023: 82 institutionsQ2 2023: 106 institutionsQ3 2023: 111 institutionsQ4 2023: 107 institutionsQ1 2024: 132 institutionsQ2 2024: 127 institutionsQ3 2024: 128 institutionsQ4 2024: 133 institutionsQ1 2025: 116 institutionsQ2 2025: 113 institutionsQ3 2025: 117 institutionsQ4 2025: 125 institutionsQ1 2026: 135 institutionsQ2 2026: 135 institutions
Value heldQ3 2024: $205.9M
Q1 2021: $125.7MQ2 2021: $96.8MQ3 2021: $58.6MQ4 2021: $51.3MQ1 2022: $171.3MQ2 2022: $142.3MQ3 2022: $142.9MQ4 2022: $146.2MQ1 2023: $183.8MQ2 2023: $307.7MQ3 2023: $211.2MQ4 2023: $227.5MQ1 2024: $331.1MQ2 2024: $301.6MQ3 2024: $205.9MQ4 2024: $196.2MQ1 2025: $117.4MQ2 2025: $103.1MQ3 2025: $141.1MQ4 2025: $132.6MQ1 2026: $129.4MQ2 2026: $122.7M
Institutions holding VYGR and their total value by quarter
QuarterHoldersValue
Q2 2026135$122.7M
Q1 2026135$129.4M
Q4 2025125$132.6M
Q3 2025117$141.1M
Q2 2025113$103.1M
Q1 2025116$117.4M
Q4 2024133$196.2M
Q3 2024128$205.9M
Q2 2024127$301.6M
Q1 2024132$331.1M
Q4 2023107$227.5M
Q3 2023111$211.2M
Q2 2023106$307.7M
Q1 202382$183.8M
Q4 202270$146.2M
Q3 202269$142.9M
Q2 202278$142.3M
Q1 202270$171.3M
Q4 202159$51.3M
Q3 202169$58.6M
Q2 202178$96.8M
Q1 2021101$125.7M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Voyager Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding VYGR in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Massachusetts Financial Services Co171,856$1.01M0.00%+28,333+19.7%Added
Bridgeway Capital Management, LLC185,109$1.08M0.02%+2,278+1.2%Added
Wellington Management Group LLP229,369$1.34M0.00%−17,623−7.1%Reduced
Citadel Advisors LLC247,636$1.45M0.00%+132,047+114.2%Added
AQR Capital Management LLC248,623$1.45M0.00%−253,752−50.5%Reduced
Bank of New York Mellon Corp249,528$1.46M0.00%−44,892−15.2%Reduced
Fiduciary Trust Co259,397$1.52M0.02%00.0%Unchanged
JPMorgan Chase & Co261,934$1.53M0.00%−13,509−4.9%Reduced
Renaissance Technologies LLC278,667$1.63M0.00%+215,467+340.9%Added
Globeflex Capital L P291,293$1.70M0.16%00.0%Unchanged
Goldman Sachs Group Inc328,326$1.92M0.00%−115,658−26.1%Reduced
Northern Trust Corp406,371$2.38M0.00%+32,210+8.6%Added
Prudential Financial Inc412,400$2.41M0.00%+297,100+257.7%Added
Vestal Point Capital, LP490,000$2.87M0.23%−110,000−18.3%Reduced
Bank of America Corp531,557$3.11M0.00%−117,203−18.1%Reduced
Morgan Stanley540,663$3.16M0.00%+43,694+8.8%Added
Federated Hermes, Inc.551,398$3.23M0.01%−2,816−0.5%Reduced
State Street Corp892,743$5.22M0.00%−896,446−50.1%Reduced
Price T Rowe Associates Inc905,820$5.30M0.00%−83,729−8.5%Reduced
Great Point Partners LLC959,953$5.62M1.69%−641,574−40.1%Reduced
Erste Asset Management GmbH1,058,378$6.19M0.07%00.0%Unchanged
Geode Capital Management, LLC1,079,509$6.32M0.00%+6,740+0.6%Added
Dimensional Fund Advisors LP1,105,044$6.46M0.00%+291,364+35.8%Added
Farallon Capital Management, L.L.C.2,292,000$13.4M0.07%00.0%Unchanged
Vanguard Group Inc3,186,427$18.6M0.00%+147,863+4.9%Added
EcoR1 Capital, LLC3,917,546$22.9M0.79%00.0%Unchanged
Armistice Capital, LLC5,200,000$30.4M0.80%00.0%Unchanged
BlackRock, Inc.5,430,430$31.8M0.00%+5,430,430New
Woodline Partners LP0$00.00%−300,000−100.0%Sold out
First Trust Advisors LP0$00.00%−120,734−100.0%Sold out
Advantage Alpha Capital Partners LP0$00.00%−110,681−100.0%Sold out
Rafferty Asset Management, LLC0$00.00%−89,242−100.0%Sold out
SummerHaven Investment Management, LLC0$00.00%−77,293−100.0%Sold out
Hussman Strategic Advisors, Inc.0$00.00%−52,500−100.0%Sold out
Alps Advisors Inc0$00.00%−38,149−100.0%Sold out
Winton Group Ltd0$00.00%−36,027−100.0%Sold out
Semanteon Capital Management, LP0$00.00%−22,715−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−18,707−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−17,352−100.0%Sold out
Profund Advisors LLC0$00.00%−16,762−100.0%Sold out
Man Group plc0$00.00%−14,957−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−12,159−100.0%Sold out
Ritholtz Wealth Management0$00.00%−11,556−100.0%Sold out
Inceptionr LLC0$00.00%−10,053−100.0%Sold out
Arcadia Investment Management Corp0$00.00%−2,000−100.0%Sold out
Pacer Advisors, Inc.0$00.00%−508−100.0%Sold out
BlackRock Inc.––––Not filed